Clinical Trial: Clinical Study of QingReMoShen Granule to Treat Idiopathic Membranous Nephropathy
Study Status: Active, not recruiting
Recruit Status: Active, not recruiting
Study Type: Interventional
Official Title: Efficacy and Safety Evaluation of QingReMoShen Granule in the Treatment of Idiopathic Membranous Nephropathy : A Randomized Double-Blind Controlled Clinical Study
Brief Summary: The purpose of this study is to evaluate the clinical safety and efficacy of QingReMoShen Granule to treat idiopathic membranous nephropathy.
Detailed Summary:
Sponsor: wanglin
Current Primary Outcome: 24-hour urine protein [ Time Frame: At the 24thweek ]
Original Primary Outcome: Same as current
Current Secondary Outcome:
- serum albumin concentration [ Time Frame: At the 24thweek ]
- eGFR [ Time Frame: At the 24thweek ]
- Alanine transaminase [ Time Frame: At the 24thweek ]
Original Secondary Outcome: Same as current
Information By: Shanghai University of Traditional Chinese Medicine
Dates:
Date Received: April 29, 2013
Date Started: November 2011
Date Completion: September 2016
Last Updated: November 30, 2015
Last Verified: November 2015
